Landwehrmeyer B, Mengod G, Palacios J M
Preclinical Research, Sandoz Pharma Ltd, Basel, Switzerland.
Eur J Neurosci. 1993 Feb 1;5(2):145-53. doi: 10.1111/j.1460-9568.1993.tb00480.x.
At least five members of the dopamine receptor family have been characterized at the gene level. D2, D3 and D4 dopamine receptors are related pharmacologically. In order to visualize the differential expression of D1, D2 and D3 receptors in rat brain we have combined in situ hybridization histochemistry with receptor autoradiography. Regions enriched with D3 messenger RNA (mRNA) included the islands of Calleja (ioC) and nucleus accumbens. Very low or undetectable levels were present in the caudate-putamen. In contrast, no D2 transcripts were observed in the islands of Calleja, but there were high levels in the nucleus accumbens, caudate-putamen (CP) and pyramidal layer of the olfactory tubercle. A comparison of the binding pattern of six dopamine receptor radioligands hitherto regarded as D2 receptor-selective showed that the islands of Calleja were intensely labelled by [125I]iodosulpride, [3H]CV 205 502 and [3H]SDZ 205 501, while the binding of [3H]spiperone, [3H]raclopride and [3H]YM 09151-2 was much lower or undetectable. Pharmacological analysis of the binding of D2/D3 ligands to the islands of Calleja and caudate-putamen suggests that binding sites in these two regions are of different pharmacology, consistent with the presence of D3 sites in the islands of Calleja and the predominance of D2 sites in the caudate. These results demonstrate the expression of D3 binding sites in the rat brain and provide a procedure to differentiate D2 and D3 receptor populations in binding studies.
多巴胺受体家族至少有五个成员已在基因水平上得到鉴定。D2、D3和D4多巴胺受体在药理学上相关。为了观察大鼠脑中D1、D2和D3受体的差异表达,我们将原位杂交组织化学与受体放射自显影相结合。富含D3信使核糖核酸(mRNA)的区域包括Calleja岛(ioC)和伏隔核。尾状核-壳核中的水平非常低或无法检测到。相比之下,在Calleja岛中未观察到D2转录本,但在伏隔核、尾状核-壳核(CP)和嗅结节的锥体细胞层中有高水平表达。对迄今被认为是D2受体选择性的六种多巴胺受体放射性配体的结合模式进行比较表明,Calleja岛被[125I]碘舒必利、[3H]CV 205 502和[3H]SDZ 205 501强烈标记,而[3H]螺哌隆、[3H]雷氯必利和[3H]YM 09151-2的结合则低得多或无法检测到。对D2/D3配体与Calleja岛和尾状核-壳核结合的药理学分析表明,这两个区域的结合位点具有不同的药理学特性,这与Calleja岛中存在D3位点以及尾状核中D2位点占优势一致。这些结果证明了大鼠脑中D3结合位点的表达,并为在结合研究中区分D2和D3受体群体提供了一种方法。